Syncromune, Inc. — Form D/A

Syncromune, Inc. of FORT LAUDERDALE, FL, a company, filed a Form D amendment with the SEC on 2025-08-21. The offering totals $144.8M, of which $111.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Jeffrey L ClelandDirectorFort Lauderdale, FL
Eamonn J HobbsDirectorFort Lauderdale, FL
Charles J LinkDirectorFort Lauderdale, FL
Joseph C MaroonDirectorFort Lauderdale, FL
Norman L SchwartzDirectorFort Lauderdale, FL
Douglas G WatsonDirectorFort Lauderdale, FL
Agustin J GagoExecutive OfficerFort Lauderdale, FL
Joseph J GerardiExecutive OfficerFort Lauderdale, FL
Eamonn J HobbsExecutive OfficerFort Lauderdale, FL
Charles J LinkExecutive OfficerFort Lauderdale, FL
Kerri-Ann L MillarExecutive OfficerFort Lauderdale, FL
Jeffrey J KrawsExecutive OfficerRockville, MD
Gregory J ChampionExecutive OfficerFort Lauderdale, FL
STEPHEN DALERelated PersonFort Lauderdale, FL
Eamonn HobbsRelated PersonFort Lauderdale, FL
Charles J. LinkRelated PersonFort Lauderdale, FL
Joseph GerardiRelated PersonFort Lauderdale, FL
Agustin GagoRelated PersonFort Lauderdale, FL
Joseph C. MaroonRelated PersonFort Lauderdale, FL
Douglas G. WatsonRelated PersonFort Lauderdale, FL
Jeffrey L. ClelandRelated PersonFort Lauderdale, FL
Norman SchwartzRelated PersonFort Lauderdale, FL
Kerri-Ann MillarRelated PersonFort Lauderdale, FL

Other filings by this issuer (4)

FiledFormOfferingSold
2026-05-11D/A$144.8M$144.8M
2024-12-17D$144.8M$50.8M
2023-10-06D/A$20.0M$14.2M
2022-11-29D$20.0M$5.3M

More